Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy

Mediators of Inflammation

Volumn 13, Issue 2, 2004, Pages 93-103

  Spillere Da Silva, Marcelo Barreto ^a   Farges, Roseli Coimbra ^a   Fröde, Tânia Silvia ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Nitric oxide; PK11195; Pleurisy; Steroid Synthesis

Indexed keywords

ADENOSINE DEAMINASE; AMINOGLUTETHIMIDE; CARRAGEENAN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NITRIC OXIDE; STEROID;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EVALUATION; EXUDATE; FEMALE; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PLEURISY; PRIORITY JOURNAL;

ADENOSINE DEAMINASE; AMINOGLUTETHIMIDE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CARRAGEENAN; DISEASE MODELS, ANIMAL; FEMALE; ISOQUINOLINES; LEUKOCYTES; MALE; MICE; NITRATES; NITRIC OXIDE; NITRITES; PLEURISY; RECEPTORS, GABA-A; STEROIDS;

ADA; ANIMALIA; MURINAE;

EID: 2542535295     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350410001688486     Document Type: Article

References (66)

1. Anholt RR, Pedersen PL, De Souza EB, Snyder SH. The peripheral-type benzodiazepine receptor: localization of the mitochondrial outer membrane. J Biol Chem 1986; 261: 576-583.
2. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 1992; 89: 3170-3174.
3. Joseph-Liauzun E, Farges R, Delmas P, Ferrara P, Loison G. The Mr 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier. J Biol Chem 1997; 272: 28102-28106.
4. Verma A, Snyder SH. Peripheral type benzodiazepine receptors. Annu Rev Pharmacol Toxicol 1989; 29: 307-322.
5. Krueger KE, Papadopoulos V. Mitochondrial benzodiazepine receptors and the regulation of steroid biosynthesis. Annu Rev Pharmacol Toxicol 1992; 32: 211-237.
6. Krueger KE. Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim Biophys Acta 1995; 1241: 453-470.
7. Besman MJ, Yanagibashi K, Lee TD, Kawamura M, Hall PF, Shively JE. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci 1989; 86: 4897-4901.
8. Barnea ER, Fares F, Gavish M. Modulatory action of benzodiazepines on human term placental steroidogenesis in vitro. Mol Cell Endocrinol 1989; 64: 155-159.
9. Papadopoulos V, Mukhin AG, Costa E, Krueger KE. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem 1990; 265: 3772-3779.
10. Amsterdam A, Suh BS. An inducible functional peripheral benzodiazepine receptor in mitochondria of steroidogenic granulosa cells. Endocrinology 1991; 129: 503-510.
11. Tsankova V, Magistrelli A, Cantoni L, Tacconi MT. Peripheral benzodiazepine receptor ligands in rat liver mitochondria: effect on cholesterol translocation. Eur J Pharmacol 1995; 294: 601-607.
12. Lacor P, Gandolfo P, Tonon MC, et al. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis. Brain Res 1999; 815: 70-80.
13. Silvestre JS, Robert V, Heymes C, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998; 273: 4883-4891.
14. Morales A, Cuellar A, Ramirez J, Vilchis F, Diaz-Sanchez V. Synthesis of steroids in pancreas: evidence of cytochrome P-450scc activity. Pancreas 1999; 19: 39-44.
15. Benavides J, Dubois A, Dennis T, Hamel E, Scatton B. Omega 3 (peripheral type benzodiazepine binding) site distribution in the rat immune system: an autoradiographic study with the photoaffinity ligand [3H]PK 14105. J Pharmacol Exp Ther 1989; 249: 333-339.
16. Canat X, Carayon P, Bouaboula M, et al. Distribution profile and properties of peripheral type benzodiazepine receptors on human hemopoetic cells. Life Sci 1993; 52: 107-118.
17. Torres SR, Fröde TS, Nardi GM, et al. Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur J Pharmacol 2000; 408: 199-211.
18. Cash R, Brough AJ, Cohen MN, Satoh PS. Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. J Clin Endocrinol Metab 1967; 27: 1239-1248.
19. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden JA. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, Pharmacol Rev 2001; 53: 527-552.
20. Wakai A, Wang JH, Winter DC, Street JT, O'Sullivan RG, Redmond HP. Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation. Shock 2001; 15: 297-301.
21. Gomez G, Apasov S, Sitkovsky MV. Immunossuppressive effects of extracellular adenosine on immune cells: implications for the pathogenesis of ADA SCID and immunomodulation. Drug Dev Res 2001; 53: 218-224.
22. 2A receptors inhibits IL-12 production by human monocytes. J Immunol 2000; 164: 436-442.
23. 2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect 2003; 5: 515-526.
24. Fröde TS, Medeiros YS. Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediat Inflamm 2001; 10: 223-227.
25. Dalmarco EM, Frode TS, Medeiros YS. Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy. Mediat Inflamm 2002; 11: 299-306.
26. Rossi A, Cuzzocrea S, Mazzon E, et al. Regulation of prostaglandin generation in carrageenan-induced pleurisy by inducible nitric oxide synthase in knockout mice. Life Sci 2003; 72: 1199-1208.
27. Saleh TSF, Calixto JB, Medeiros YS. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Br J Pharmacol 1996; 118: 811-819.
28. Fröde TS, Souza GE, Calixto JB. The effects of IL-6 and IL-10 and their specific antibodies in the acute inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine 2002; 17: 149-156.
29. Giusti G, Galanti B. Adenosine deaminase: colorimetric method. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis, New York: Verlac Chemie, 1984: 315-323.
30. Saleh TSF, Calixto JB, Medeiros YS. Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 1999; 20: 723-741.
31. Torres SR, Nardi GM, Ferrara P, Ribeiro-do-Valle RM, Farges RC. Potential role of peripheral benzodiazepine receptors in inflammatory responses. Eur J Pharmacol 1999; 385: 1-2.
32. Myers R, Manjil LG, Frackowiak RS, Cremer JE. 3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci Lett 1991; 133: 20-24.
33. Veenman L, Leschiner S, Spanier I, Weisinger G, Weizman A, Gavish M. PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J Neurochem 2002; 80: 917-927.
34. Regoli D, Nsa Allogho S, Rizzi A, Gobeil FJ. Bradykinin receptors and their antagonists. Eur J Pharmacol 1998; 348: 1-10.
35. Pagaelow I, Werner H, Vietinghoff G, Wartner U. Release of cytokines from isolated lung strips by bradykinin. Inflamm Res 1995; 44: 306-311.
36. Hayashi R, Yamashita N, Matsui S, et al. Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur Respir J 2000; 16: 452-458.
37. Ahluwalia A, Perretti M. Involvement of bradykinin B1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1 beta in vivo in the mouse. J Immunol 1996; 156: 269-274.
38. McLean PG, Ahluwalia A, Perretti M. Association between kinin B(1) receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules. J Exp Med 2000; 192: 367-380.
39. Phagoo SB, Reddi K, Anderson KD, Leeb-Lundberg LM, Warburton D. Bradykinin B1 receptor up-regulation by interleukin-1beta and B1 agonist occurs through independent and synergistic intracellular signaling mechanisms in human lung fibroblasts. J Pharmacol Exp Ther 2001; 298: 77-85.
40. Oh-Ishi S, Hayashi I, Hayashi M, et al. Evidence for a role of the plasma kallikrein-kinin system in acute inflammation: reduced exudation during carrageenin- and kaolin-pleurisies in kininogen-deficient rats. Agents Actions 1986; 18: 450-454.
41. Oh-Ishi S. Biological regulation by the kallikrein-kinin system: a study with a kininogen-deficient rat strain. Nippon Yakurigaku Zasshi 1993; 101: 209-218.
42. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology 1992; 131: 710-714.
43. Majima M, Kawashima N, Hiroshi I, Katori M. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Br J Pharmacol 1997; 121: 723-730.
44. Modeer T, Anduren I, Yucel-Lindberg T. Bradykinin synergistically stimulates interleukin 6 production in human gingival fibroblasts challenged with interleukin 1 or tumour necrosis factor alpha. Cytokine 1998; 10: 26-31.
45. Pesquero JB, Araujo RC, Heppenstall PA, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA 2000; 97: 8140-8145.
46. Pan ZK, Ye RD, Christiansen SC, Jagels MA, Bokoch GM, Zuraw BL. Role of the Rho GTPase in bradykinin-stimulated nuclear factor-kappaB activation and IL-1 beta gene expression in cultured human epithelial cells. J Immunol 1998; 160: 3038-3045.
47. Zhu YM, Bradbury DA, Pang L, et al. Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-independent activation of NF-kappaB. J Biol Chem 2003; 278: 29366-29375.
48. Huang CD, Tliba O, Panettieri RA Jr, Amrani Y. Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol 2003; 28: 330-338.
49. Saleh TS, Calixto JB, Medeiros YS. Pro-inflammatory effects induced by bradykinin in a murine model of pleurisy. Eur J Pharmacol 1997; 331: 43-52.
50. Saban MR, Saban R, Bjorling DE. Kinetics of peptide-induced release of inflammatory mediators by the urinary bladder. Br J Urol 1997; 80: 742-747.
51. Cocchiara R, Bongiovanni A, Albeggiani G, Azzolina A, Geraci D. Substance P selectively activates TNF-alpha mRNA in rat uterine immune cells: a neuroimmune link. Neuroreport 1997; 8: 2961-2964.
52. Lambert N, Lescoulie PL, Yassine-Diab B, Enault G, Mazieres B, De Preval C, Cantagrel A. Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes. Clin Exp Immunol 1998; 113: 269-275.
53. Zavala F, Taupin V, Descamps-Latscha B. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6. J Pharmacol Exp Ther 1990; 255: 442-450.
54. Kawamura M, Hatanaka K, Saito M, et al. Are the anti-inflammatory effects of dexamethasone responsible for inhibition of the induction of enzymes involved in prostanoid formation in rat carrageenin-induced pleurisy? Eur J Pharmacol 2000; 400: 127-135.
55. Hatanaka K, Kawamura M, Ogino M, Saito M, Ogino K, Matsuo S, Harada Y. Expression and function of cyclooxygenase-2 in mesothelial cells during late phase of rat carrageenin-induced pleurisy. Life Sci 1999; 65: 161-166.
56. Tracey WR, Nakane M, Kuk J, Budzik G, Klinghofer V, Harris R, Carter G. The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat. J Pharmacol Exp Ther 1995; 273: 1295-1299.
57. Wei XQ, Charles IG, Smith A, et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375: 408-411.
58. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT, Currie MG. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996; 118: 829-838.
59. Cuzzocrea S, Zingarelli B, Hake P, Salzman AL, Szabo C. Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 1998; 24: 450-459.
60. Matsumura M, Kakishita H, Suzuki M, Banba N, Hattori Y. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci 2001; 69: 1067-1077.
61. Cuzzocrea S, Mazzon E, Sautebin L, et al. The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat. Mol Med 2001; 7: 478-487.
62. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000; 407: 538-541.
63. Hafezi-Moghadam A, Simoncini T, Yang E, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8: 473-479.
64. Szabo C, Salzman AL, Ischiropoulos H. Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 1995; 372: 229-232.
65. Cuzzocrea S, Zingarelli B, Costantino G, Szabo A, Salzman AL, Caputi AP, Szabo C. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 1997; 121: 1065-1074.
66. Cronstein BN, Montesinos MC, Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci USA 1999; 96: 6377-6381.